×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $5.94 B
Last 13-F Filed: Q2 2025
Concentration in top 10: 66.19%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
RNAAVIDITY BIOSCIENCES INC3.41%7,266,031$206,355,280965,62315.33%$28.413F
EWTXEDGEWISE THERAPEUTICS INC2.15%9,902,633$129,823,519993,54211.15%$13.1113F
TYRATYRA BIOSCIENCES INC1.93%12,198,625$116,740,8411,561,33514.68%$9.5713F
GHRSGH RESEARCH PLC1.55%7,676,697$93,578,936732,04910.54%$12.1913F
TSHATAYSHA GENE THERAPIES INC0.90%23,555,648$54,413,54712,683,145116.65%$2.3113F
SLDBSOLID BIOSCIENCES INC.0.81%7,997,510$48,304,9602,186,18737.62%13D
HOWLWEREWOLF THERAPEUTICS INC0.12%6,681,307$7,282,625536,4268.73%$1.0913F
CTMXCYTOMX THERAPEUTICS INC0.10%2,661,331$6,041,2211,661,331166.13%$2.2713F